Literature DB >> 11720882

Molecular cloning of a functional promoter of the human plakoglobin gene.

E Pötter1, S Braun, U Lehmann, G Brabant.   

Abstract

OBJECTIVE: Plakoglobin (Pg) is the only cytoplasmic protein component common to both junctional complexes mediating cell-cell adhesion, adherens junctions and desmosomes. In these complexes Pg appears to act as a linker protein anchoring transmembrane proteins of the cadherin superfamily to the actin cytoskeleton and intermediate filament system respectively. Intercellular adhesion is frequently disturbed in skin diseases and in carcinomas, enabling tumour progression and metastasis. Whereas Pg expression is lost in some thyroid tumours and carcinoma cell lines, little information on Pg gene regulation is currently available owing to a lack of promoter studies. DESIGN AND METHODS: We have cloned and sequenced genomic DNA from a human library that resulted in 979 bp upstream of the published Pg cDNA. The transcriptional start was mapped by rapid amplification of cDNA ends. Methylation-specific PCR of bisulfite-modified cell line DNA was applied to probe the methylation status of a promoter-associated CpG island. Reporter-gene constructs of various promoter fragments were transiently transfected in thyroid carcinoma cell lines and their activities were determined by luciferase measurements. RESULTS AND
CONCLUSIONS: A 1 kb DNA fragment harbouring a functional promoter of the human Pg gene was cloned and characterized. The sequence lacks a canonical TATA box, but contains putative CCAAT boxes as well as various putative binding sites for transcription factors, among them SP1 and AP2, proximal to the transcriptional start. Considerable promoter activity was found in thyroid cell lines and deletion analysis indicated that a 300 bp region proximal to the 5'-untranslated region of the mRNA represents the minimal promoter of the human Pg gene. As cells lacking endogenous Pg expression were found to contain methylated CpG dinucleotides in a CpG island located around the transcriptional start site, it is suggested that epigenetic mechanisms such as DNA methylation contribute to dysregulated Pg expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720882     DOI: 10.1530/eje.0.1450625

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  6 in total

Review 1.  Desmosomes: regulators of cellular signaling and adhesion in epidermal health and disease.

Authors:  Jodi L Johnson; Nicole A Najor; Kathleen J Green
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.

Authors:  Carsten Müller-Tidow; Björn Steffen; Thomas Cauvet; Lara Tickenbrock; Ping Ji; Sven Diederichs; Bülent Sargin; Gabriele Köhler; Matthias Stelljes; Elena Puccetti; Martin Ruthardt; Sven deVos; Scott W Hiebert; H Phillip Koeffler; Wolfgang E Berdel; Hubert Serve
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 3.  The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth.

Authors:  Cornelia Dietrich; Bernd Kaina
Journal:  Carcinogenesis       Date:  2010-01-27       Impact factor: 4.944

4.  Plakoglobin: role in tumorigenesis and metastasis.

Authors:  Zackie Aktary; Manijeh Pasdar
Journal:  Int J Cell Biol       Date:  2012-03-08

5.  Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.

Authors:  Yozo Mitsui; Hiroaki Yasumoto; Taichi Nagami; Miho Hiraki; Naoko Arichi; Noriyoshi Ishikawa; Asuka Araki; Riruke Maruyama; Yuichiro Tanaka; Rajvir Dahiya; Hiroaki Shiina
Journal:  Oncotarget       Date:  2014-04-30

6.  Candidate target genes for loss of heterozygosity on human chromosome 17q21.

Authors:  L De Marchis; C Cropp; Z M Sheng; S Bargo; R Callahan; L DeMarchis
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.